(Aditya Shaw, Intern Journalist): India is moving fast on the coronavirus vaccine. Trial of ICMR-Bharat Biotech’s Covaxin has also started in Bhubaneswar, Odisha. Covaxin was applied to a select few who had come forward to be part of this important test. He said that all those who were vaccinated have been kept under observation and they are “absolutely fine”. At the same time, the Serum Institute of India (SII) is conducting the third phase clinical trial of BCG vaccine. According to the Biotechnology Department (DBT), about six thousand health workers and those facing greater danger have registered for the trial.
Can RBCG increase immunity against Corona? Serum Institute of India Phase III to test the effect of BCG Vaccine VPM1002 in reducing infection and its side effects in older people, patients with other complex diseases, and medical personnel who are most at risk from the coronavirus Performing clinical trials. This test will explore whether bacillus-Chalmette-Guerin- (RBCG) is effective in strengthening immunity against the coronavirus.
BCG vaccine is used in the treatment of many diseases.
To protect against TB, all newborns are given the BCG vaccine under the National Child Immunization Program. Tuberculosis is caused by bacteria and most lungs are affected. Renu Swaroop, secretary of DPT and chairperson of BIRSC, said that BGC is a certified vaccine and its evaluation is a practical approach in treating diseases other than tuberculosis.
About Post Author
